The North America Hemostats Market would witness market growth of 4.8% CAGR during the forecast period (2022-2028).
The demand for the hemostats devices is also driven by an increase in the number of surgeries in a variety of fields, including orthopaedic, gynaecological, reconstructive, and cardiac surgery as well as an increase in the number of cancers that require surgical procedures. Additionally, throughout the forecast period, new innovations by key competitors and an increase in the number of product approvals for hemostasis devices are anticipated to create significant prospects for the market.
Hemostatic forceps often feature serrations along the jaw and are curved or straight to grab both small and large blood vessels. During a surgical operation, they are also utilised to grab medium to heavy tissue. These forceps contain a ratchet-style locking mechanism that is used to clamp blood arteries. These are routinely employed during surgical procedures, especially during complicated surgeries. Hemostats also are available in a different form for use in surgery, where these products are used to treat surgical incisions and wounds. These are simple for doctors to employ and come in the form of topical hemostats or sealants.
The industry has benefited from the government's reimbursement regulations in the North American region. For wound and incision closure, tissue sealants, tissue adhesives, and adhesion prevention techniques have taken the place of conventional sutures. The expansion of the regional hemostats market is anticipated to be aided by the burgeoning medical tourism industry, rising purchasing power, quickly growing healthcare infrastructure, and rising public knowledge of healthcare procedures. Along with this, more hospitals and surgical centers, more emerging markets, and increased industry research and development efforts would open up lucrative opportunities for the adoption of hemostatic.
The US market dominated the North America Hemostats Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $951.3 million by 2028. The Canada market is poised to grow at a CAGR of 7.2% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 6.2% during (2022 - 2028).
Based on Application, the market is segmented into Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, and Others. Based on Formulation, the market is segmented into Matrix & Gel, Sheet & Pad, Powder, Sponge, and Others. Based on Type, the market is segmented into Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Hemostats Market is Estimated to reach $3.7 Billion by 2028, at a CAGR of 5.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Baxter International, Inc., B. Braun Melsungen AG, Teleflex, Inc., Medtronic PLC, Johnson & Johnson, Pfizer, Inc., Stryker Corporation, Integra LifeSciences Holdings Corporation, and Artivion, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Application
- Orthopedic Surgery
- General Surgery
- Neurological Surgery
- Cardiovascular Surgery
- Reconstructive Surgery
- Gynecological Surgery
- Others
By Formulation
- Matrix & Gel
- Sheet & Pad
- Powder
- Sponge
- Others
By Type
- Thrombin Based
- Combination
- Oxidized Regenerated Cellulose Based
- Gelatin Based
- Collagen Based
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Becton, Dickinson and Company
- Baxter International, Inc.
- B. Braun Melsungen AG
- Teleflex, Inc.
- Medtronic PLC
- Johnson & Johnson
- Pfizer, Inc.
- Stryker Corporation
- Integra LifeSciences Holdings Corporation
- Artivion, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Hemostats Market, by Application
1.4.2 North America Hemostats Market, by Formulation
1.4.3 North America Hemostats Market, by Type
1.4.4 North America Hemostats Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Hemostats Market by Application
3.1 North America Orthopedic Surgery Market by Country
3.2 North America General Surgery Market by Country
3.3 North America Neurological Surgery Market by Country
3.4 North America Cardiovascular Surgery Market by Country
3.5 North America Reconstructive Surgery Market by Country
3.6 North America Gynecological Surgery Market by Country
3.7 North America Others Market by Country
Chapter 4. North America Hemostats Market by Formulation
4.1 North America Matrix & Gel Market by Country
4.2 North America Sheet & Pad Market by Country
4.3 North America Powder Market by Country
4.4 North America Sponge Market by Country
4.5 North America Others Market by Country
Chapter 5. North America Hemostats Market by Type
5.1 North America Thrombin Based Market by Country
5.2 North America Combination Market by Country
5.3 North America Oxidized Regenerated Cellulose Based Market by Country
5.4 North America Gelatin Based Market by Country
5.5 North America Collagen Based Market by Country
5.6 North America Others Market by Country
Chapter 6. North America Hemostats Market by Country
6.1 US Hemostats Market
6.1.1 US Hemostats Market by Application
6.1.2 US Hemostats Market by Formulation
6.1.3 US Hemostats Market by Type
6.2 Canada Hemostats Market
6.2.1 Canada Hemostats Market by Application
6.2.2 Canada Hemostats Market by Formulation
6.2.3 Canada Hemostats Market by Type
6.3 Mexico Hemostats Market
6.3.1 Mexico Hemostats Market by Application
6.3.2 Mexico Hemostats Market by Formulation
6.3.3 Mexico Hemostats Market by Type
6.4 Rest of North America Hemostats Market
6.4.1 Rest of North America Hemostats Market by Application
6.4.2 Rest of North America Hemostats Market by Formulation
6.4.3 Rest of North America Hemostats Market by Type
Chapter 7. Company Profiles
7.1 Becton, Dickinson and Company
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Baxter International, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.3 B. Braun Melsungen AG
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.4 Teleflex, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Acquisition and Mergers:
7.5 Medtronic PLC
7.5.1 Company overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisition and Mergers:
7.5.6 SWOT Analysis
7.6 Johnson & Johnson
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental &Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent strategies and developments:
7.6.5.1 Geographical Expansions:
7.6.6 SWOT Analysis
7.7 Pfizer, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional & Segmental Analysis
7.7.4 Research & Development Expense
7.8 Stryker Corporation
7.8.1 Company Overview
7.8.2 Financial Analysi9
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Integra LifeSciences Holdings Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental & Regional Analysis
7.9.4 Research & Development Expenses
7.10. Artivion, Inc. (CryoLife, Inc.)
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expenses
TABLE 1 North America Hemostats Market, 2018 - 2021, USD Million
TABLE 2 North America Hemostats Market, 2022 - 2028, USD Million
TABLE 3 North America Hemostats Market by Application, 2018 - 2021, USD Million
TABLE 4 North America Hemostats Market by Application, 2022 - 2028, USD Million
TABLE 5 North America Orthopedic Surgery Market by Country, 2018 - 2021, USD Million
TABLE 6 North America Orthopedic Surgery Market by Country, 2022 - 2028, USD Million
TABLE 7 North America General Surgery Market by Country, 2018 - 2021, USD Million
TABLE 8 North America General Surgery Market by Country, 2022 - 2028, USD Million
TABLE 9 North America Neurological Surgery Market by Country, 2018 - 2021, USD Million
TABLE 10 North America Neurological Surgery Market by Country, 2022 - 2028, USD Million
TABLE 11 North America Cardiovascular Surgery Market by Country, 2018 - 2021, USD Million
TABLE 12 North America Cardiovascular Surgery Market by Country, 2022 - 2028, USD Million
TABLE 13 North America Reconstructive Surgery Market by Country, 2018 - 2021, USD Million
TABLE 14 North America Reconstructive Surgery Market by Country, 2022 - 2028, USD Million
TABLE 15 North America Gynecological Surgery Market by Country, 2018 - 2021, USD Million
TABLE 16 North America Gynecological Surgery Market by Country, 2022 - 2028, USD Million
TABLE 17 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 18 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 19 North America Hemostats Market by Formulation, 2018 - 2021, USD Million
TABLE 20 North America Hemostats Market by Formulation, 2022 - 2028, USD Million
TABLE 21 North America Matrix & Gel Market by Country, 2018 - 2021, USD Million
TABLE 22 North America Matrix & Gel Market by Country, 2022 - 2028, USD Million
TABLE 23 North America Sheet & Pad Market by Country, 2018 - 2021, USD Million
TABLE 24 North America Sheet & Pad Market by Country, 2022 - 2028, USD Million
TABLE 25 North America Powder Market by Country, 2018 - 2021, USD Million
TABLE 26 North America Powder Market by Country, 2022 - 2028, USD Million
TABLE 27 North America Sponge Market by Country, 2018 - 2021, USD Million
TABLE 28 North America Sponge Market by Country, 2022 - 2028, USD Million
TABLE 29 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 30 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 31 North America Hemostats Market by Type, 2018 - 2021, USD Million
TABLE 32 North America Hemostats Market by Type, 2022 - 2028, USD Million
TABLE 33 North America Thrombin Based Market by Country, 2018 - 2021, USD Million
TABLE 34 North America Thrombin Based Market by Country, 2022 - 2028, USD Million
TABLE 35 North America Combination Market by Country, 2018 - 2021, USD Million
TABLE 36 North America Combination Market by Country, 2022 - 2028, USD Million
TABLE 37 North America Oxidized Regenerated Cellulose Based Market by Country, 2018 - 2021, USD Million
TABLE 38 North America Oxidized Regenerated Cellulose Based Market by Country, 2022 - 2028, USD Million
TABLE 39 North America Gelatin Based Market by Country, 2018 - 2021, USD Million
TABLE 40 North America Gelatin Based Market by Country, 2022 - 2028, USD Million
TABLE 41 North America Collagen Based Market by Country, 2018 - 2021, USD Million
TABLE 42 North America Collagen Based Market by Country, 2022 - 2028, USD Million
TABLE 43 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 44 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 45 North America Hemostats Market by Country, 2018 - 2021, USD Million
TABLE 46 North America Hemostats Market by Country, 2022 - 2028, USD Million
TABLE 47 US Hemostats Market, 2018 - 2021, USD Million
TABLE 48 US Hemostats Market, 2022 - 2028, USD Million
TABLE 49 US Hemostats Market by Application, 2018 - 2021, USD Million
TABLE 50 US Hemostats Market by Application, 2022 - 2028, USD Million
TABLE 51 US Hemostats Market by Formulation, 2018 - 2021, USD Million
TABLE 52 US Hemostats Market by Formulation, 2022 - 2028, USD Million
TABLE 53 US Hemostats Market by Type, 2018 - 2021, USD Million
TABLE 54 US Hemostats Market by Type, 2022 - 2028, USD Million
TABLE 55 Canada Hemostats Market, 2018 - 2021, USD Million
TABLE 56 Canada Hemostats Market, 2022 - 2028, USD Million
TABLE 57 Canada Hemostats Market by Application, 2018 - 2021, USD Million
TABLE 58 Canada Hemostats Market by Application, 2022 - 2028, USD Million
TABLE 59 Canada Hemostats Market by Formulation, 2018 - 2021, USD Million
TABLE 60 Canada Hemostats Market by Formulation, 2022 - 2028, USD Million
TABLE 61 Canada Hemostats Market by Type, 2018 - 2021, USD Million
TABLE 62 Canada Hemostats Market by Type, 2022 - 2028, USD Million
TABLE 63 Mexico Hemostats Market, 2018 - 2021, USD Million
TABLE 64 Mexico Hemostats Market, 2022 - 2028, USD Million
TABLE 65 Mexico Hemostats Market by Application, 2018 - 2021, USD Million
TABLE 66 Mexico Hemostats Market by Application, 2022 - 2028, USD Million
TABLE 67 Mexico Hemostats Market by Formulation, 2018 - 2021, USD Million
TABLE 68 Mexico Hemostats Market by Formulation, 2022 - 2028, USD Million
TABLE 69 Mexico Hemostats Market by Type, 2018 - 2021, USD Million
TABLE 70 Mexico Hemostats Market by Type, 2022 - 2028, USD Million
TABLE 71 Rest of North America Hemostats Market, 2018 - 2021, USD Million
TABLE 72 Rest of North America Hemostats Market, 2022 - 2028, USD Million
TABLE 73 Rest of North America Hemostats Market by Application, 2018 - 2021, USD Million
TABLE 74 Rest of North America Hemostats Market by Application, 2022 - 2028, USD Million
TABLE 75 Rest of North America Hemostats Market by Formulation, 2018 - 2021, USD Million
TABLE 76 Rest of North America Hemostats Market by Formulation, 2022 - 2028, USD Million
TABLE 77 Rest of North America Hemostats Market by Type, 2018 - 2021, USD Million
TABLE 78 Rest of North America Hemostats Market by Type, 2022 - 2028, USD Million
TABLE 79 Key information – Becton, Dickinson and Company
TABLE 80 Key Information – Baxter International, Inc.
TABLE 81 key Information – B. Braun Melsungen AG
TABLE 82 key Information – Teleflex, Inc.
TABLE 83 Key Information – Medtronic PLC
TABLE 84 Key Information – Johnson & Johnson
TABLE 85 Key Information – Pfizer, Inc.
TABLE 86 key Information – Stryker Corporation
TABLE 87 Key Information – Integra LifeSciences Holdings Corporation
TABLE 88 Key Information – Artivion, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 Swot analysis: Becton, Dickinson and company
FIG 3 Swot analysis: Medtronic plc
FIG 4 SWOT analysis: Johnson & Johnson